Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study.
ESMO Open
; 8(6): 102071, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-38016249
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Nivolumab
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
ESMO Open
Year:
2023
Document type:
Article
Country of publication:
Reino Unido